CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 120 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $102,000 | -28.7% | 20,000 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $143,000 | -73.7% | 20,000 | -51.2% | 0.02% | -77.9% |
| Q1 2019 | $544,000 | +72.7% | 41,000 | +2.5% | 0.10% | +31.6% |
| Q4 2018 | $315,000 | -43.1% | 40,000 | -20.0% | 0.08% | +5.3% |
| Q3 2018 | $554,000 | -17.4% | 50,000 | 0.0% | 0.08% | -25.7% |
| Q2 2018 | $671,000 | -31.2% | 50,000 | -33.3% | 0.10% | -30.8% |
| Q1 2018 | $975,000 | -78.8% | 75,000 | -85.0% | 0.15% | -73.9% |
| Q4 2017 | $4,600,000 | +712.7% | 500,000 | +612.1% | 0.56% | +645.3% |
| Q3 2017 | $566,000 | -2.4% | 70,210 | -30.1% | 0.08% | +56.2% |
| Q2 2017 | $580,000 | +346.2% | 100,420 | +232.4% | 0.05% | +140.0% |
| Q1 2017 | $130,000 | +400.0% | 30,210 | +98.6% | 0.02% | +400.0% |
| Q4 2016 | $26,000 | – | 15,210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |